Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care
PR Newswire —
CASTELVECCHIO PASCOLI, Italy, Nov. 6, 2025 /PRNewswire/ -- Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived therapies, announces its participation at the International Primary Immunodeficiencies Congress (IPIC) 2025, taking place in Prague, Czech Republic,...